Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Doxorubicin (DOX) is widely used as an effective chemotherapeutic agent for cancers; however, DOX induces cardiac toxicity, called DOX-induced cardiomyopathy. Although DOX-induced cardiomyopathy is known to be...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Takaaki Furihata, Satoshi Maekawa, Shingo Takada, Naoya Kakutani, Hideo Nambu, Ryosuke Shirakawa, Takashi Yokota and Shintaro Kinugawa Tags: Research Source Type: research
More News: Actos | Cancer | Cancer & Oncology | Cardiology | Cardiomyopathy | Drugs & Pharmacology | Heart | Toxicology